Move to Strike: Amendment to Arsenic Legislation Strips Bill of Its Meaning

A bill to ban Roxarsone and other arsenic-based drugs from Maryland poultry production (H.B. 167) was undermined just hours before it passed the House of Delegates on Monday.  An amendment adopted by the House states that the ban will not apply to any arsenic-based drug approved by the Food and Drug Administration (FDA).  Under federal law, all drugs—including those that contain arsenic—must be approved by FDA before they can be sold.  Because the amendment exempts all FDA-approved drugs, the amendment exempts all arsenical drugs.  The bill would no longer protect Marylanders and consumers of Maryland chickens from increased arsenic exposure if companies begin using Roxarsone or an alternative arsenic-based drug once again. Read More >